Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01923129 · ClinicalTrials.gov registry record · NA
Optimal Duration of Indwelling Urinary Catheter Following Pelvic Surgery
A NA study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 142
- Enrollment target
NCT01923129 is a NA study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 142 participants.
The verdict
NCT01923129, a NA study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 142 participants
- Enrollment target
Study Summary
There is no general agreement about the optimal duration of postoperative urinary drainage, with relevant literature reporting durations ranging from 1 to 10 days. The available research supporting the routine use of prolonged catheterization is limited and studies investigating early removal following infraperitoneal colorectal surgery have largely been underpowered to form valid practice conclusions. The aim of the investigators study is to determine whether a postoperative colorectal patient can safely have an indwelling catheter removed on postoperative day one (24 hours following surgery) with the addition of a study medication (prazosin), without a statistically significant difference in the incidence of urinary retention compared to the standard, accepted approach of delayed removal (72 hours postoperatively). Patients undergoing laparoscopic and open pelvic colorectal surgery below the peritoneal reflection for both benign and malignant conditions will be randomized into two groups: group one will have the catheter removed on postoperative day 3 (72 hours postoperatively) Group 2 will have a dose of the alpha-blocker prazosin given 6 hours prior to catheter removal and will have the urinary catheter removed on postoperative day 1 (24 hours postoperatively).
Interventions
- DRUG Prazosin given 6 hours prior to catheter removal in the 24 hour group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2012-11-30 |
| Est. Completion | 2017-11-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01923129
The ClinicalTrials.gov registry entry for NCT01923129 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Prazosin given 6 hours prior to catheter removal in the 24 hour group is the first listed.
NCT01923129 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01923129 about?
NCT01923129 is a clinical study titled "Optimal Duration of Indwelling Urinary Catheter Following Pelvic Surgery". There is no general agreement about the optimal duration of postoperative urinary drainage, with relevant literature reporting durations ranging from 1 to 10 days. The available research supporting the routine use of prolonged catheterization is limited and studies investigating early removal follow...
What is the current status of trial NCT01923129?
This trial is currently completed. It is a NA study. The enrollment target is 142 participants. The study started on 2012-11-30. Estimated completion is 2017-11-22.
What interventions are being tested in trial NCT01923129?
The interventions under investigation include: Prazosin given 6 hours prior to catheter removal in the 24 hour group (DRUG).
Who is sponsoring clinical trial NCT01923129?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.